PCH
DNTH icon

Polar Capital Holdings’s Dianthus Therapeutics DNTH Stock Holding History

Polar Capital Holdings’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.3M Sell
1,018,726
-57,283
-5% -$5M 0.23% 85
2026
Q1 		$90.3M Buy
1,076,009
+71,281
+7% +$4.13M 0.32% 69
2025
Q4 		$41.4M Buy
1,004,728
+256,725
+34% +$9.95M 0.16% 110
2025
Q3 		$29.4M Buy
+748,003
New +$19.1M 0.14% 120

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Polar Capital Holdings's DNTH Position: Q2 2026 in Review

Polar Capital Holdings reduced its Dianthus Therapeutics (DNTH) stake by 5.3% in Q2 2026, selling an estimated $5M and leaving 1,018,726 shares worth $99.3M. The position accounts for 0.23% of the portfolio, ranked #85.

Polar Capital Holdings first reported a position in DNTH in Q3 2025 and has held it in 4 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Polar Capital Holdings held 1,018,726 shares of Dianthus Therapeutics worth $99.3M as of Q2 2026.
  • Polar Capital Holdings sold 57,283 Dianthus Therapeutics shares in Q2 2026, an estimated $5M.
  • Dianthus Therapeutics made up 0.23% of Polar Capital Holdings's portfolio in Q2 2026, its #85 holding.
  • Polar Capital Holdings first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.